TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 138 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,000 | -25.6% | 9,686 | +26.5% | 0.00% | – |
| Q2 2023 | $117,000 | -12.0% | 7,655 | +29.2% | 0.00% | – |
| Q1 2023 | $133,000 | -50.4% | 5,923 | -53.5% | 0.00% | – |
| Q4 2022 | $268,000 | +235.0% | 12,740 | +292.1% | 0.00% | – |
| Q3 2022 | $80,000 | -45.6% | 3,249 | -46.4% | 0.00% | – |
| Q2 2022 | $147,000 | -6.4% | 6,065 | -0.8% | 0.00% | – |
| Q1 2022 | $157,000 | -61.2% | 6,113 | -53.1% | 0.00% | – |
| Q4 2021 | $405,000 | +101.5% | 13,038 | +57.0% | 0.00% | – |
| Q3 2021 | $201,000 | +240.7% | 8,306 | +104.9% | 0.00% | – |
| Q2 2021 | $59,000 | +37.2% | 4,053 | +132.7% | 0.00% | – |
| Q1 2021 | $43,000 | +4200.0% | 1,742 | +3315.7% | 0.00% | – |
| Q4 2020 | $1,000 | – | 51 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |